90 likes | 291 Views
The report provides an estimation of 2013 opioid revenues and forecast consumption and revenues until 2023 in the five major Western European countries: the UK, Germany, France, Italy and Spain. The estimated revenues for 2013 are highest in the UK, which held a share of 52%, followed by Germany with 20%. Spain had the lowest in terms of both consumption (3.3%) and revenues (2.2%). Browse full report @ http://bit.ly/1Cz476r
E N D
Aarkstore- Opioids Market Overview to 2023 –Opioids in Western Europe To buy this Report Visit http://www.aarkstore.com
Discounted Market Research Reports available on Aarkstore.com Offer valid till 28th February, 2015 • For more inquiries, contact at +91 9987295242 / 022-27564953 • Email: enquiry@aarkstore.com To buy this Report Visit http://www.aarkstore.com
Summary The report Opioids Market in Western Europe provides an estimation of 2013 opioid revenues and forecast consumption and revenues until 2023 in the five major Western European countries: the UK, Germany, France, Italy and Spain. The estimated revenues for 2013 are highest in the UK, which held a share of 52%, followed by Germany with 20%. Spain had the lowest in terms of both consumption (3.3%) and revenues (2.2%).Their use for medicinal purposes has been highly controversial for several decades. Although recognized as potent painkillers, potential for misuse is high. As a result, all regulatory authorities strive to maintain a fine balance between enforcing strict regulations that will crack down on illicit usage but at the same time ensure accessibility for genuine medical purposes. Amidst concerns regarding inadequate pain management due to low accessibility, there are also concerns regarding a lack of significant clinical evidence of their role in managing chronic pain. However, new abuse-deterrent technologies provide an incentive to prescribe more opioids in pain management by alleviating concerns over misuse potential. The approval of such new drugs and formulations has proved a new impetus to growth in opioid usage in the five major Western European countries.
Scope The report covers the five major Western European countries (the UK, Germany, France, Italy and Spain) and includes - - An overview of opioids in pain management and substitution treatment, and usage constraints for both- Brief analysis of recent approvals of key abuse-deterrent drugs and their impact on consumption and market growth- Country snapshots, comprising key regulations, consumption, market revenues, market forecasts and key drivers and barriers- An overview of new abuse-deterrent technologies and profiles of key pipeline products Browse Complete Report – http://www.aarkstore.com/pharmaceuticals-healthcare/62511/opioids-market-overview-to-2023-opioids-in-western-europe
Key Reasons to Purchase • Gain a perspective of the opioids market size and key drivers and challenges that dictate the market trends in each of the five major countries in Western Europe • Gauge the impact of key recently approved abuse-deterrent technologies on opioidusage • Develop an understanding of how the regulatory landscape affects market potential and growth in each country • Identify the key molecules that are currently the leading players in each region and those that hold the highest potential in the forecast period • Scan the pipeline for innovative products with abuse-deterrent technologies that could have an impact on opioid usage in the pain management market
Table of Contents • Executive summary • Opioids: an overview • Opioids in pain management • Usage constraints • International conventions • Drug misuse in Western Europe • Extent of drug misuse • Impact of abuse-deterrent drugs • Key abuse-deterrent products • Unmet need in pain management • Requirement and consumption • Key activities to promote usage • Regulatory landscape
Related Market Research Report • Digna Biotech, S.L. - Product Pipeline Review - 2014 • Daewoong Pharmaceutical Co., Ltd. - Product Pipeline Review – 2014 • Generic Drugs Market in Japan 2015-2019 • CytRx Corporation - Product Pipeline Review - 2014 • Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 • Chimerix, Inc. - Product Pipeline Review - 2014 • Health Discovery Corporation (HDVY) - Financial and Strategic SWOT Analysis Review • Cardioxyl Pharmaceuticals, Inc. - Product Pipeline Review – 2014 • Lupus Erythematosus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 • Metastatic Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
About Aarkstore Enterprise • Aarkstore Enterprise provides Industry and Market Analysis and Research Report with expertise and technology knowledge on business improvement and market acquisition. • Aarkstore achieved its debut pad in the year 2008 to explore, work on assignments and cater worldwide clients and business giants with business research on trends, markets and technologies. The latest set of applications guarantees active analysis and Market Research understanding for budding enterpriser and consultants to relate industry ground research.
Contact Us Office Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Telefax No: +91 22 4127 6660 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit http://www.aarkstore.com OR Mail us at contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news